NYSE:CVD Covance (CVD) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CVD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Covance alerts: Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Covance Stock (NYSE:CVD)Covance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services.Read More Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. CVD Stock News HeadlinesFebruary 23, 2024 | msn.comNew study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular healthJanuary 26, 2024 | msn.comClinical study supports the long-lasting impacts of typhoid conjugate vaccineMay 5, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. October 8, 2023 | msn.com“Unblocked” movement to tackle burden of cardiovascular diseasesOctober 6, 2023 | reuters.comAntidumping separate rate process and pitfalls importers should considerSeptember 24, 2023 | investing.comCVD Historical DataAugust 26, 2023 | msn.comFeeling safe from crime ‘reduces heart attack risk’July 27, 2023 | finance.yahoo.comCVV - CVD Equipment CorporationMay 5, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. May 22, 2023 | benzinga.comHolter ECG Market is Expected to Reach $558 million | MarketsandMarkets.May 8, 2023 | technews.tmcnet.comUCARDIA ANNOUNCES ACQUISITION OF PHAS3; LAUNCHES CARDIOLOGIST PRACTICE REMOTE PATIENT MONITORING OFFERINGJuly 21, 2022 | marketwatch.comAnalgesics Market 2022 Size, Demand, Outlook, Trends, Revenue, Future Growth Opportunities till 2030May 10, 2022 | finance.yahoo.comPeople Who Have Had COVID-19 More Likely to Develop Cardiovascular Disease: New Report Highlights the Need to Refocus on Cardiovascular CareMay 4, 2022 | thestreet.comCramer's 'Mad Money' Recap: Stake Out AeroVironmentMarch 14, 2022 | msn.comPeople with serious mental illness more likely to have heart disease – studyMarch 13, 2022 | msn.comPeople with serious mental illness more likely to suffer from heart disease – studyJanuary 31, 2022 | ca.finance.yahoo.com1 Top Healthcare Stock to Buy Low TodayJanuary 21, 2022 | thestreet.comCovance Stock Hits New 52-Week High (CVD)October 26, 2021 | finance.yahoo.comNovartis launches Not Another Minute to educate Canadians and take action to bend the curve of cardiovascular disease (CVD)September 28, 2021 | msn.comWorld Heart Day 2021: Know all about the date, history, significance and themeSee More Headlines Receive CVD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covance and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/04/2015Today5/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:CVD CUSIP22281610 CIK1023131 Webwww.covance.com Phone+1-609-4524440FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report CVD Stock Analysis - Frequently Asked Questions How were Covance's earnings last quarter? Covance Inc (NYSE:CVD) released its quarterly earnings data on Wednesday, February, 4th. The healthcare company reported $0.97 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.97. The healthcare company had revenue of $634 million for the quarter, compared to the consensus estimate of $631.30 million. What other stocks do shareholders of Covance own? Based on aggregate information from My MarketBeat watchlists, some companies that other Covance investors own include Allena Pharmaceuticals (ALNA), Laboratory Co. of America (LH), Arbutus Biopharma (ABUS), Ampliphi Biosciences (APHB), Asterias Biotherapeutics (AST), Catalyst Biosciences (CBIO), Crestwood Equity Partners (CEQP), Cisco Systems (CSCO), Fate Therapeutics (FATE) and Flexion Therapeutics (FLXN). This page (NYSE:CVD) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covance Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.